APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Walker, Brian A., Wardell, Christopher P., Murison, Alex, Boyle, Eileen M., Begum, Dil B., Dahir, Nasrin M., Proszek, Paula Z., Melchor, Lorenzo +13 more·2015·Nature Communications
DOI 10.1038/ncomms7997

Cited by (313)

Items 201–300 of 313

  1. BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability
    Kathy Situ, Haohui Duan, Stephen K. Godin, Joshua Yang, Gabrielle Q. McCloskey, Basim Naeem, Margaret K. Gillis, Muhammad H. Zeb, Silvi Salhotra, Pratha Rawal et al. · 2025 · Nature Communications
  2. B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells
    Zhiquan Wang, Huihuang Yan, Justin C. Boysen, Charla R. Secreto, Renee C. Tschumper, Dania Ali, Qianqian Guo, Jian Zhong, Jiaqi Zhou, Haiyun Gan et al. · 2022 · Blood Cancer Journal
  3. Clinical and genomic characterization of mutational signatures across human cancers
    Jianlong Liao, Jing Bai, Tao Pan, Haozhe Zou, Yueying Gao, Jing Guo, Qi Xu, Juan Xu, Yongsheng Li, Xia Li · 2022 · International Journal of Cancer
  4. Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma
    Mahshid Rahmat, Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco, Daniel Heilpern-Mallory, Katarina Nilsson, David M. Dorfman, J Engreitz et al. · 2024 · Cancer Research
  5. Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions
    Monika Chojnacka, Benjamin T. Diamond, Ola Landgren, Francesco Maura · 2022 · Seminars in Oncology
  6. The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
    Zhigang Yi, Tao Ma, Jia Liu, Wenting Tie, Yanhong Li, Jun Yuan Bai, Lijuan Li, Liansheng Zhang · 2022 · Frontiers in Immunology
  7. Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma
    Nicholas E. Bingham, Jaynish S. Shah, Daniel Wong, Sueh‐li Lim, Krystal Bergin, Anna Kalff, Antonia Reale, Tiffany T. Khong, Sridurga Mithraprabhu, Andrew G Spencer · 2025 · Blood Cancer Journal
  8. A new strategy for exploring the hierarchical structure of cancers by adaptively partitioning functional modules from gene expression network
    Junmei Xu, Runyu Jing, Yuan Liu, Yongcheng Dong, Zhining Wen, Menglong Li · 2016 · Scientific Reports
  9. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
    Yasuhiro Kazuma, Kotaro Shirakawa, Yusuke Tashiro, Hiroyuki Yamazaki, Ryosuke Nomura, Yoshihito Horisawa, Suguru Takeuchi, Emani Stanford, Yoshinobu Konishi, Hiroyuki Matsui et al. · 2022 · Scientific Reports
  10. Evolution of Multiple Myeloma from a Genomic Perspective
    Maura, Francesco, Samur, Mehmet, Munshi, Nikhil · 2026 · Blood
  11. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
    Agnès Daudignon, Wendy Cuccuini, Claire Bracquemart, Catherine Godon, Benoît Quilichini, Dominique Penther · 2023 · Current Research in Translational Medicine
  12. Non-targeting siRNA-mediated responses are associated with apoptosis in chemotherapy-induced senescent skin cancer cells
    Gabriela Betlej, Dominika Błoniarz, Anna Lewińska, Maciej Wnuk · 2022 · Chemico-Biological Interactions
  13. Characterizing the mutational landscape of MM and its precursor MGUS.
    Akanksha Farswan, Anubha Gupta, Lingaraja Jena, Vivek Ruhela, Gurvinder Kaur, Ritu Gupta · 2022 · PubMed Central
  14. Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies
    Kevin M. McBride, Hyunsuk Kil, Yunxiang Mu, Joshua B. Plummer, Jae‐Ho Lee, Maciej J. Żelazowski, Manu M. Sebastian, Martı́n C. Abba, C. Marcelo Aldaz · 2019 · Frontiers in Oncology
  15. The past, present, and future of myeloma staging and risk prognostication
    Mehmet Baysal, Kelley L. Julian, Douglas Weston Sborov, Amandeep Godara, Brian Lee McClune, Jens G. Lohr, Gliceida Galarza Fortuna, Ghulam Rehman Mohyuddin · 2025 · The Oncologist
  16. Plasmablastic Lymphoma
    Michele Bibas · 2023 · Elsevier eBooks
  17. High WEE1 expression is independently linked to poor survival in multiple myeloma
    Anish K. Simhal, Ross Firestone, Jung Hun Oh, Viswatej Avutu, Larry Norton, Malin L. Hultcrantz, Saad Z. Usmani, Kylee H. Maclachlan, Joseph O. Deasy · 2025 · Blood Cancer Journal
  18. The ratio of brain to liver glucose activity and disease activity in multiple myeloma
    Sarah Dingli, Paul Rothweiler, Moritz Binder, Joselle Cook, Morie Abraham Gertz, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Shaji Kunnathu Kumar, Mustaqeem Ahmad Siddiqui et al. · 2025 · Blood Cancer Journal
  19. Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma
    Aihetaimujiang Anwaier, Yuanyuan Qu, Shiqi Ye, Xi Tian, Shuxuan Zhu, Siqi Zhou, Guohai Shi, Yu Zhu, Hailiang Zhang, Dingwei Ye et al. · 2025 · Neoplasia
  20. The importance of cytogenetic and molecular aberrations in multiple myeloma
    Artur J. Jurczyszyn, Grzegorz Charliński, Anna Suska, David H. Vesole · 2021 · Acta Haematologica Polonica
  21. Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression
    Yuta Masuda, Rei Ishihara, Yuki Murakami, Saki Watanabe, Yuta Asao, Nanami Gotoh, Tetsuhiro Kasamatsu, Hisashi Takei, Nobuhiko Kobayashi, Takayuki Saitoh et al. · 2022 · International Journal of Hematology
  22. Still high risk? A review of translocation t(14;16) in multiple myeloma
    Hira S. Mian, Martin Kaiser, Rafaël Fonseca · 2024 · American Journal of Hematology
  23. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC
    Brian A. Walker · 2018 · Methods in molecular biology
  24. Disease heterogeneity, prognostication and the role of targeted therapy in multiple myeloma
    Saurabh Zanwar, Shaji Kunnathu Kumar · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  25. China's potential role in humanitarian assistance
    Andrea Binder, Björn Conrad · 2009
  26. RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA
    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe G.M. Leone · 2024 · Mediterranean Journal of Hematology and Infectious Diseases
  27. MAFB: a key regulator of myeloid commitment involved in hematological diseases
    Antonio Benedetto Ventura, Tiziana Loconte, Antonio Negri, Luigi Viggiano, Giuseppe Fiermonte, Sabino Ciavarella, Attilio Guarini, Giacomo Volpe · 2025 · Cell Death Discovery
  28. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
    Takashi Kanamori, Masashi Sanada, Masaki Ri, Hiroo Ueno, Dai Nishijima, Takahiko Yasuda, Takuto Tachita, Tomoko Narita, Shigeru Kusumoto, Atsushi Inagaki et al. · 2020 · British Journal of Haematology
  29. The numerous facets of 1q21+ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review)
    Na Liu, Zhanzhi Xie, Hao Li, Luqun Wang · 2024 · Oncology Letters
  30. The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward
    Meghana Ram, Molly Fraser, Junia Vieira Dos Santos, Rafail Nikolaos Tasakis, Ariana Islam, Jannah Usama Abo-Donia, Samir Sunil Parekh, Alessandro Laganà · 2024 · Pharmacogenomics and Personalized Medicine
  31. Multiple myeloma etiology and treatment
    Humaira Sadaf, Hanna Hong, Mohsin Maqbool, Kylin A. Emhoff, Jianhong Lin, Shan Yan, Faiz Anwer, Jianjun Zhao · 2022 · Journal of Translational Genetics and Genomics
  32. Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival
    Anish K. Simhal, Kylee H. Maclachlan, Rena Elkin, Jiening Zhu, Larry Norton, Joseph O. Deasy, Jung Hun Oh, Saad Z. Usmani, Allen Tannenbaum · 2023 · Blood Cancer Journal
  33. Contribution of cytosine desaminases of AID/APOBEC family to carcinogenesis
    Irina V. Zotova, Elena Igorevna Stepchenkova, Youri I. Pavlov · 2019 · Biological Communications
  34. A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
    Mariarosaria Sessa, Francesco Cavazzini, Maurizio Cavallari, Gian Matteo Rigolin, Antonio Cuneo · 2020 · Genes
  35. Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    Peeter Karihtala, Katja Porvari, Outi Kilpivaara · 2022 · Cancer Genomics & Proteomics
  36. Revealing the impact of recurrent and rare structural variants in multiple myeloma
    Even Holth Rustad, Venkata D. Yellapantula, Dominik Głodzik, Kylee H. Maclachlan, Benjamin T. Diamond, Eileen Mary Boyle, Cody Ashby, Patrick Blaney, Gunes Gundem, Malin L. Hultcrantz et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Whole genome sequencing provides evidence of two biologically and clinically distinct entities of asymptomatic monoclonal gammopathies: progressive versus stable myeloma precursor condition
    Bénedith Oben, Guy Froyen, Kylee H. Maclachlan, Daniel A. Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata D. Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T. Diamond et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
    Hira S. Mian, Martin Kaiser, Rafaël Fonseca · 2024 · Blood Cancer Journal
  39. A systematic literature review on clonal evolution events preceding relapse in multiple myeloma
    Maja Zimmer Jakobsen, Rasmus Froberg Brøndum, Henrik Gregersen, Hanne Due, Karen Dybkær · 2024 · Critical Reviews in Oncology/Hematology
  40. Multiple myeloma: Insights into underlying mechanisms, advances in diagnostic and therapeutic modalities
    Rohitash Yadav, Jitendra Kumar Chaudary, Khushboo Bisht, Puneet Dhamija, Pankaj Kumar Chaudhary, Uttam Kumar Nath, Neeraj Kumar Jain · 2025 · Seminars in Oncology
  41. Molecular and immunological determinants of long-term survival in multiple myeloma
    Khanmi Kasomva, Kritika Yadav, Siegfried Janz, Binod Dhakal, Sridhar Rao · 2025 · Blood Advances
  42. Sex differences in the clinical presentation of patients with newly diagnosed multiple myeloma
    Krystle L. Ong, Kevin D. Arnold, Meredith C. Wessel, Gayatri Ravi, Faith E. Davies, Gareth John Morgan, EE Brown · 2026 · Cancer
  43. Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma—A Pilot Study
    Lorenz Oelschläger, Axel Künstner, Friederike Frey, Theo Leitner, Lisa Beatrice Leypoldt, Niklas Reimer, Niklas Gebauer, Lorenz Bastian, Katja Christina Weisel, Verena‐Wilbeth Sailer et al. · 2024 · International Journal of Molecular Sciences
  44. Cytogenetic and molecular aberrations at diagnosis and in prognosis of multiple myeloma
    Beenu Thakral, Anjanaa Vijayanarayanan, Leonard Jeffrey Medeiros, Pei Lin · 2025 · Seminars in Diagnostic Pathology
  45. Clinical impact of MYC abnormalities in plasma cell myeloma
    Rolando García, Weina Chen, Prasad R. K. Koduru · 2018 · Cancer Genetics
  46. [Advances on Recognizing and Managing Tumor Heterogeneity].
    Rui Zhong, Hui Li, Shuang Zhang, Jingjing Liu, Ying Cheng · 2018 · Europe PMC (PubMed Central)
  47. Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
    Marta Lionetti, Matteo Da Vià, Francesco Albano, Antonino Neri, Niccolò Bolli, Pellegrino Musto · 2021 · Cancers
  48. Case report: Thoracic and lumbar plasma cell myeloma mimicking hemangiomas on MRI and 18F-FDG PET/CT
    Xianwen Hu, Wei Xiong, Shun Li, Xue Li, Jiong Cai, Pan Wang, Dandan Li · 2022 · Frontiers in Medicine
  49. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
    Jacob Jahn, Benjamin T. Diamond, Jeffrey Hsu, Skye Montoya, Tulasigeri M. Totiger, Ola Landgren, Francesco Maura, Justin Taylor · 2023 · Leukemia Research
  50. MyeVAE: a multi-modal variational autoencoder for risk profiling of newly diagnosed multiple myeloma
    Jia Geng Chang, Jianbin Chen, Guo-Liang Chew, Wee Joo Chng · 2025 · BMC Artificial Intelligence
  51. Deciphering epigenetic crosstalk in multiple myeloma pathogenesis and treatment
    Shamila D. Alipoor, Mariusz Shrestha, An Liu, Hong Chang · 2026 · Clinical Epigenetics
  52. Plasmablastic lymphoma: from genetics to treatment
    Fabian Frontzek, Stephan Hailfinger, Georg Lenz · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
  53. Molecular Diagnostics of Plasma Cell Neoplasms
    Megan J. Fitzpatrick, Mandakolathur R. Murali, Valentina Nardi · 2023 · Surgical pathology clinics
  54. Mechanisms of Global and Region-Specific Control of Mutagenesis
    Youri I. Pavlov, Artem G. Lada, Corinn E. Grabow, Elena Igorevna Stepchenkova · 2016 · Springer eBooks
  55. Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects
    Anna Yu. Aksenova, Anna S. Zhuk, Elena Igorevna Stepchenkova, Sergei Vasil'evich Gritsaev · 2022 · Clinical oncohematology
  56. Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
    Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin T. Diamond, Paolo Corradini et al. · 2023 · medRxiv
  57. Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk
    Patrick Hagen, Mark Sellin, Stephanie Berg, Jiwang Zhang · 2022 · Annals of Hematology
  58. Molecular genetic aberrations in the pathogenesis of multiple myeloma
    Ivyna Pau Ni Bong, Ezalia Esa · 2023 · Asian Biomedicine
  59. Approach to High-Risk Multiple Myeloma
    Xiaoyi Chen, Gaurav Varma, Faith E. Davies, Gareth John Morgan · 2024 · Hematology/Oncology Clinics of North America
  60. Molecular classification of tissue from a transformed non-Hogkin’s lymphoma case with unexpected long-time remission
    Julie Støve Bødker, Marianne Tang Severinsen, Tarec Christoffer El‐Galaly, Rasmus Froberg Brøndum, Maria Bach Laursen, Steffen Falgreen, Mette Nyegaard, Alexander Schmitz, Lasse Hjort Jakobsen, Anna A. Schönherz et al. · 2017 · Experimental Hematology and Oncology
  61. Integration of Genomics Into Treatment: Are We There Yet?
    Gareth John Morgan, John R Jones · 2017 · American Society of Clinical Oncology Educational Book
  62. Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
    Е. Л. Назарова, Natalia V. Minaeva, М Н Хоробрых, Э Е Сухорукова, В. И. Шардаков, Igor V. Paramonov, N. А. Zorina · 2018 · Clinical oncohematology
  63. Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma
    Haoqiang Zhang, Minghui Li, Peng Gao, Ping-Heng Lan, Bo Fan, Xin Xiao, Yajie Lu, Guojing Chen, Zhen Wang · 2016 · Orthopaedic Surgery
  64. Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma
    T. V. Abramova, Т. Н. Обухова, Elena Olegovna Gribanova, Maksim Valerevich Solovev, М. В. Фирсова, Ol’ga Mikhailovna Votyakova, Sergei M. Kulikov, Yulia A. Chabaeva, Irina Vladimirovna Galtseva, Larisa Pavlovna Mendeleeva · 2021 · Гематология и трансфузиология
  65. A study to identify novel biomarkers associated with multiple myeloma
    Iyshwarya Bhaskar Kalarani, Ramakrishnan Veerabathiran · 2023 · Siberian Journal of Oncology
  66. Molecular basis of multiple myeloma
    Sabina Ševčı́ková, Dorota Nižňanská, Monika Vlachová, Jana Gregorobá, Jana Kotašková, Marie Jarošová · 2024 · Klinicka onkologie
  67. A rare case of multiple myeloma with double translocations: t(11;14) and t(14;16)
    Mina Meseha, Vishw Patel, Kirolos Sekla, Ping Yang, David Glen Coffey · 2025 · Journal of Hematopathology
  68. Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer
    Tomáš Konečný, Nate Zadirako, Arpine Grigoryan, Melina Tamazyan, Sveta Mnatsakanyan, Luiza Stepanyan, Henry Loeffler‐Wirth, Sean Bourdelais, Gabriel Mednick, Chloe Delepine et al. · 2026 · Oncogene
  69. CAR-T Therapy for Solid Tumors: Development of New Strategies
    Samuel D. Bernal · 2019 · Trends in Immunotherapy
  70. Targeted therapy of multiple myeloma
    Shan Zhou, Renxi Wang · 2021 · Exploration of Targeted Anti-tumor Therapy
  71. What Is Genomic High-Risk Myeloma?
    Faith E. Davies, Brian A. Walker · 2022 · Hemato
  72. Multiple Myeloma
    Loren J. Joseph · 2022 · Advances in Molecular Pathology
  73. Non-homogeneous Poisson and renewal processes as spatial models for cancer mutation
    Hengyuan Miao, Erçan E. Kuruoğlu, Tao Xu · 2023 · Computational Biology and Chemistry
  74. Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum
    Aya Nakaya, Hirohiko Shibayama, Nobuhiko Uoshima, Ryosuke Yamamura, Satoshi Yoshioka, Kazunori Imada, Yuji Shimura, Masaaki� Hotta, Toshimitsu Matsui, Satoru Kosugi et al. · 2023 · Leukemia Research Reports
  75. Epidemiology and Pathophysiology of Multiple Myeloma
    Malin L. Hultcrantz, Gareth John Morgan, Ola Landgren · 2017 · Hematologic malignancies
  76. From Bench to Bedside
    Gareth John Morgan, Eileen Mary Boyle, Faith E. Davies · 2021 · The Cancer Journal
  77. Az idősödés során jellemző genetikai és epigenetikai változások és a gammopátiák progressziója •
    S. Veronika Urbán, László Lajos Kocsis, Gábor Mikala · 2023 · Hematológia–Transzfuziológia
  78. On the road to molecular prognostication in SMM
    Salomon Manier · 2019 · Leukemia
  79. Genetic modifiers of APOBEC-induced mutagenesis
    Tony M. Mertz, Elizabeth Rice-Reynolds, Ly Thi Huong Nguyen, Anna J. Wood, Nicholas Bray, Debra Mitchell, Kirill S. Lobachev, Steven A. Roberts · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  80. An Investigation of 53BP1 in Multiple Myeloma
    Justin Simms · 2017 · Libraries and Cultural Resources (University of Calgary)
  81. Prognosis of Myeloma/Genetics of Myeloma
    Sébastien Robiou-du-Pont, Jill Corre, Hervé Avet‐Loiseau · 2017 · Springer eBooks
  82. Deep sequencing as an approach to understanding the complexity and improving the treatment of multiple myeloma
    Louis S. Williams, Jessica Caro, Beatrice M. Razzo, Eileen Mary Boyle, Gareth John Morgan · 2020 · Expert Review of Precision Medicine and Drug Development
  83. Mutation-dependent treatment approaches for patients with complex multiple myeloma
    Foteini Theodorakakou, Meletios Athanasios Dimopoulos, Efstathios Kastritis · 2021 · Expert Review of Precision Medicine and Drug Development
  84. Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation
    Meera Mohan, Parameswaran Hari, Anikó Szabó, Binod Dhakal, Saurabh Chhabra, Anita D’Souza · 2021 · Leukemia Research
  85. [Progress in clonal evolution of multiple myeloma].
    Yan Wang, G An, L. Qiu · 2021 · Europe PMC (PubMed Central)
  86. CAR-T Therapy for Solid Tumors: Development of New Strategies
    Marvin De los Santos, Samuel D. Bernal · 2020 · Trends in Immunotherapy
  87. [Multiple myeloma with chromothripsis: three cases report].
    Chaofan Wu, Zihang Zeng, Q R Wang, L J Wen, Qianqian Wang, Lingzhi Yan, Shiwei Jin, X L Shi, S N Chen, Chengcheng Fu et al. · 2022 · PubMed Central
  88. [Update on biology of primary plasma cell leukemia].
    Q Li, Chunyan Sun, Yu Hu · 2022 · PubMed Central
  89. Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients
    Hasna Hamdaoui, Badreddine Nouadi, Oumaima Benlarroubia, Faiza Chbel, Chaimaa Saadoune, Faïza Bennis, Afaf Lamzouri, Fatima Chegdani · 2023 · Leukemia Research Reports
  90. High expression of APOBEC3G predicts unfavorable prognosis and immune infiltration in patients with acute myeloid leukemia
    Fengjiao Chang, Jinhang Hu, Jie Lin, Fang Liu · 2023 · International Conference on Bioinformatics and Biomedical Technology (ICBBT)
  91. Plasma cell disorders
    Caitlin L. Costello, Rafaël Fonseca · 2022
  92. Plasma cell disorders: monoclonal gammopathy of undetermined significance and multiple myeloma
    Caitlin L. Costello · 2025
  93. c-MAF protein expression in multiple myeloma
    M. V. Solov’eva, M. V. Solov’ev, M. V. Melnikova, A. M. Kovrigina, T. N. Obukhova, L. P. Mendeleeva · 2025 · Oncohematology
  94. Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database
    Julia L. Varghese, Christopher Paul Venner, Martha Louzada, Donna Ellen Reece, Darrell J. White, Smriti Sharma, Jiandong Su, Michael Patvin Chu, Victor Hugo Jimenez-Zepeda, Arleigh B. Robertson McCurdy et al. · 2025 · Clinical Lymphoma Myeloma & Leukemia
  95. Additional file 1 of Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction
    Zheng, Xingyu, Amos, Christopher I., Frost, H. Robert · 2021 · Figshare
  96. Additional file 1 of APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types
    G. Maria Jakobsdottir, Daniel S. Brewer, Colin Cooper, Catherine Green, David C. Wedge · 2022 · Figshare
  97. Navigating the evolving management of smoldering multiple myeloma
    Mohammad Bakri Hammami, Rafael Renatino Canevarolo, Ariosto Siqueira Silva, Melissa Alsina, Nagi B. Kumar, Rachid Baz, Kenneth H. Shain · 2026 · HemaSphere
  98. Rôle du long ARN non-codant CRNDE dans le myélome multiple
    Antoine David · 2019 · theses.fr (ABES)
  99. Développement et évaluation d'anticorps bispécifiques dans le traitement du Myélome multiple
    Maxime Fayon · 2019 · theses.fr (ABES)
  100. Identification par séquençage de l'exome de la dérégulation des voies de signalisation dans le myélome multiple et leurs conséquences fonctionnelles, notamment sur la voie p53
    Benoît Tessoulin · 2018 · theses.fr (ABES)